Questions? +1 (202) 540-8337 Login
Trusted News Since 1995
A service for global professionals · Monday, March 19, 2018 · 437,580,023 Articles · 3+ Million Readers

Lifestyle Drugs 2017 Global Market Expected to Grow at CAGR Of 2.87% and Forecast To 2021

Wiseguyreports.Com Publish New Market Research Report On-“Lifestyle Drugs 2017 Global Market Expected to Grow at CAGR Of 2.87% and Forecast To 2021”.

PUNE, INDIA, May 4, 2017 / --

Lifestyle Drugs Market 2017

About Lifestyle Drugs Market
Lifestyle disease is associated with the way an individual or group of people live. Some of the lifestyle diseases include depression, sexual dysfunction, anti-aging, baldness, and obesity.

The analysts forecast the global lifestyle drugs market to grow at a CAGR of 2.87% during the period 2017-2021.

Covered in this report
The report covers the present scenario and the growth prospects of the global lifestyle drugs market for 2017-2021. To calculate the market size, the report considers sales of lifestyle drugs in the market.

The market is divided into the following segments based on geography:
• Americas

Request a Sample Report @

The report, Global Lifestyle Drugs Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
• Allergan
• Eli Lilly
• Pfizer

Other prominent vendors
• Acerus Pharmaceuticals
• Alkermes
• Amorepacific
• AndroScience
• Anterios
• AstraZeneca
• Avanir Pharmaceuticals
• Avolynt
• Celtaxsys
• Cerecor
• Corcept Therapeutics
• Cosmo Pharmaceuticals
• CTC Bio
• Dermira
• Dong-A ST
• Euthymics Bioscience
• Foamix
• Follicum
• Forendo Pharma
• Futura Medical Developments
• Galderma
• Hanmi Pharmaceutical
• Incyte
• Intrepid Therapeutics
• Ion Channel Innovations
• iX Biopharma
• Johnson & Johnson
• Legacy Healthcare
• LEO Pharma
• H. Lundbeck
• Luye America Pharmaceuticals
• Merck
• Minerva Neurosciences
• MSI Methylation Sciences
• Neuralstem
• Novan
• Novartis
• Novo-Nordisk
• Palatin Technologies
• Paratek Pharmaceuticals
• Photocure
• Revance Therapeutics
• Rhythm Pharmaceuticals
• S1 Biopharma
• Sage Therapeutics
• Samumed
• Sanofi
• Sigma-Tau Pharmaceuticals
• Strategic Science & Technologies
• Sumitomo Dainippon Pharma
• Takeda
• TetraLogic Pharmaceuticals
• TherapeuticsMD
• Valeant Pharmaceuticals
• VistaGen Therapeutics
• XBiotech
• Yuhan
• Zafgen

Market driver
• Lifestyle changes
• For a full, detailed list, view our report

Market challenge
• Patent expiries
• For a full, detailed list, view our report

Market trend
• Increase in M&A
• For a full, detailed list, view our report

Key questions answered in this report
• What will the market size be in 2021 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

Complete Report Details @

Table of Contents

PART 01: Executive summary
PART 02: Scope of the report
PART 03: Research Methodology

PART 04: Introduction
Key market highlights

PART 05: An overview of lifestyle diseases

PART 06: Market landscape
Market overview
Five forces analysis

PART 07: Pipeline landscape

PART 08: Market segmentation by therapy area
Dermatology (acne, anti-aging, and baldness)
Sexual dysfunction

PART 09: Geographical segmentation
Lifestyle drugs market in Americas
Lifestyle drugs market in EMEA
Lifestyle drugs market in APAC

PART 10: Market drivers
Lifestyle changes
Development of novel therapeutics
Increasing demand from older population

PART 11: Impact of drivers

PART 12: Market challenges
Patent expiries
Side effects coupled with product recalls
Presence of alternative therapies and treatments

PART 13: Impact of drivers and challenges

PART 14: Market trends
Increase in M&A
Growing focus on development of drugs for new indications
Emerging lifestyle diseases

PART 15: Vendor landscape
Competitive scenario

PART 16: Key vendor analysis
Eli Lilly

Buy Now @

Norah Trent
Wise Guy Consultants Pvt. Ltd.
+1 (339) 368 6938 (US)/+91 841 198 5042 (IND)
email us here

Powered by EIN Presswire